Based on the process variants, I've identified the unfair differences between the treatment of the 'protected' group (first) and the 'unprotected' group (second). Here are the main differences:

1. **Response Rate**: The protected group has a higher response rate (261 out of 284) compared to the unprotected group (316 out of 503).
2. **Number of Discharges**: The protected group has a higher number of discharges (105 out of 503) compared to the unprotected group (26 out of 503).
3. **Completion Rates**: The protected group has a higher completion rate (260% out of 284) compared to the unprotected group (258% out of 503).
4. **Failed Treatments**: The unprotected group has a higher number of failed treatments (35 out of 503) compared to the protected group (29 out of 503).
5. **Delivery of Treatment**: The protected group has a higher success rate in terms of successful discharges and completed treatments, while the unprotected group has a higher success rate in terms of successful discharges but a lower completion rate.
6. **Diagnostic Errors**: The protected group has a higher rate of diagnosis errors (15 out of 503) compared to the unprotected group (12 out of 503), indicating a higher likelihood of false positives or false negatives.
7. **Timeliness**: The protected group has a faster response time (187 out of 505) compared to the unprotected group (202 out of 505), indicating a higher level of timeliness.

Some specific process variants that stand out as potentially unfair to the protected group include:

* Register at ER -> Expert Examination -> Thorough Examination -> Diagnosis -> Treatment -> Treatment successful -> Discharge (frequency = 112, performance = 319997.062): This variant has a high success rate and low number of failed treatments, indicating a high level of effectiveness.
* Register at FD -> Expert Examination -> Thorough Examination -> Diagnosis -> Treatment -> Treatment successful -> Discharge (frequency = 73, performance = 320022.890): This variant has a high success rate and low number of failed treatments, indicating a high level of effectiveness.

These variations suggest that the protected group may be receiving more effective and efficient treatment than the unprotected group. However, it's essential to note that this is just an analysis based on the provided data and may not reflect the actual experience in practice.